Phase
Alumni community member
Xinnate
The research of Xinnate´s co-founder at Lund University has resulted in proprietary platform technology within advanced wound care, which consists of specific peptides appearing in nature’s host defense. The company has developed a lead candidate that is currently in clinical trials for inflammatory skin diseases.
Did you know?
The body’s natural defence to promote healing is the secret in Xinnate´s gel.
Non-invasive cardiac pressure monitoring device
Accelerated drug development in oncology
Unique stem cell therapeutics
3D cell culture systems
Rapid Diagnostics for Multi-pathogen detection
Individualised information of the intestinal flora
Imaging solutions for life sciences
Novel probiotics for therapeutic effect
Treatments based on nature’s own defenses
Analysis services for drug development
Pest control solutions for bed bugs
Neonatal Lung Analyzer
Prebiotics for irritable bowel syndrome
Nanotechnology based infection control
Excellence in designing & executing drug discovery
Models for autoimmune & inflammatory conditions
Ultrasensitive cancer diagnostics & monitoring
Structural biology & drug discovery services
Male-Factor Infertility Diagnostics
Customized in vitro and in vivo services
Stroke detection device
Wound treatment gel
Regenerative medicine & cancer
